Panel To Rank U.K. Priorities

LONDON—Industrial, government and scientific leaders here are about to launch a new effort to decide how best to spend the U.K.'s research dollars. The tripartite forum—as yet unnamed—is expected to be announced shortly by the government, which hopes to attract a well-known industrialist as its chairman. The idea for such a group came from the government's Advisory Council for Applied Research and Development (ACARD). The Council, a group of senior industrial and government res

Written byDavid Fishlock
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The idea for such a group came from the government's Advisory Council for Applied Research and Development (ACARD). The Council, a group of senior industrial and government research managers, is chaired by Sir Francis Tombs, the chief executive of Rolls-Royce.

The Council has wrestled unsuccessfully with the question of setting priorities for national R&D efforts since the late 1970s. Each time a program cut was considered, noted a former chairman, someone on the Council would rise passionately to its defense and the group would change its mind.

The new forum will spearhead a drive to persuade private industry to spend more on R&D. Greater spending on both in-house and contract research is needed, government officials argue, for Britain to remain competitive with Japan and the United States.

Fairclough believes that Britain needs a substantial and secure core budget for academic science—and, despite the view of many in academia, he said ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA